RANDALL TINDLE: Open Payments
NPI 1609368075 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 16 payments from 10 companies in 2025. Trend: 2023 $105 · 2024 $174 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $68 |
| Novo Nordisk Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Eisai Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: OTEZLA, XIFAXAN, REXULTI, Rybelsus, REPATHA, Leqembi, Flucelvax, TRELEGY ELLIPTA.
Industry payments across KS — which companies pay providers there.
